Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. | Genome Med | 2022 | 35986347 | PubTator, text mining | PubMed |
| A gene expression map of host immune response in human brucellosis. | Front Immunol | 2022 | 35979363 | PubTator, text mining | PubMed |
| Antibody therapy reverses biological signatures of COVID-19 progression. | Cell Rep Med | 2022 | 35977462 | PubTator, text mining | PubMed |
| Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. | Elife | 2022 | 35975985 | PubTator, text mining | PubMed |
| XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity. | J Virol | 2022 | 35972291 | PubTator, text mining | PubMed |
| Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. | Front Immunol | 2022 | 35967341 | PubTator, text mining | PubMed |
| Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients. | Genome Med | 2022 | 35962405 | PubTator, text mining | PubMed |
| Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections. | Int J Mol Sci | 2022 | 35955436 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion. | Microb Pathog | 2022 | 35944840 | PubTator, text mining | PubMed |
| GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. | Front Cell Infect Microbiol | 2022 | 35937703 | PubTator, text mining | PubMed |
| Advances in understanding interferon-mediated immune responses to enteric viruses in intestinal organoids. | Front Immunol | 2022 | 35935957 | PubTator, text mining | PubMed |
| IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway. | Virol Sin | 2022 | 35934228 | PubTator, text mining | PubMed |
| Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection. | Nat Commun | 2022 | 35933486 | PubTator, text mining | PubMed |
| USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. | Cell Death Dis | 2022 | 35933402 | PubTator, text mining | PubMed |
| Cytokine Activation Reveals Tissue-Imprinted Gene Profiles of Mesenchymal Stromal Cells. | Front Immunol | 2022 | 35924240 | PubTator, text mining | PubMed |
| Recapitulating influenza virus infection and facilitating antiviral and neuroprotective screening in tractable brain organoids. | Theranostics | 2022 | 35910807 | PubTator, text mining | PubMed |
| The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. | Int J Mol Sci | 2022 | 35897826 | PubTator, text mining | PubMed |
| Usutu Virus Infects Human Placental Explants and Induces Congenital Defects in Mice. | Viruses | 2022 | 35893684 | PubTator, text mining | PubMed |
| Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. | Front Immunol | 2022 | 35874714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=26